Acute Erythroblastic Leukemia Trials


Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes

Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes The recruitment status of this study is unknown becaus…

Continue reading about Clinical Trial Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes

Studying Tissue Samples to Learn More About Drug Resistance in Patients With Acute Myeloid Leukemia

Studying Tissue Samples to Learn More About Drug Resistance in Patients With Acute Myeloid Leukemia The recruitment status of this study is unknown because the information has not been verified recently. …

Continue reading about Clinical Trial Studying Tissue Samples to Learn More About Drug Resistance in Patients With Acute Myeloid Leukemia

ABT-888 and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders

ABT-888 and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders This study is currently recruitin…

Continue reading about Clinical Trial ABT-888 and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders

Imatinib Mesylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Who Have Received Chemotherapy

Imatinib Mesylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Who Have Received Chemotherapy This study is ongoing, but not recruiting participants. Fi…

Continue reading about Clinical Trial Imatinib Mesylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Who Have Received Chemotherapy

Clofarabine and Temsirolimus in Treating Older Patients With Relapsed or Refractory Acute Myeloid Leukemia

Clofarabine and Temsirolimus in Treating Older Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML1107) This study is ongoing, but not recruiting participants. …

Continue reading about Clinical Trial Clofarabine and Temsirolimus in Treating Older Patients With Relapsed or Refractory Acute Myeloid Leukemia

Cladribine, Cytarabine, and Imatinib Mesylate in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Blastic Phase Chronic Myelogenous Leukemia

Cladribine, Cytarabine, and Imatinib Mesylate in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Blastic Phase Chronic Myelogenous Leukemia The recruitment status of this study is unknown because…

Continue reading about Clinical Trial Cladribine, Cytarabine, and Imatinib Mesylate in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Blastic Phase Chronic Myelogenous Leukemia

Bortezomib and Vorinostat in Treating Patients With High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia

Bortezomib and Vorinostat in Treating Patients With High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia This study has been terminated. ( Met protocol stop rule [i.e., extreme toxicity] …

Continue reading about Clinical Trial Bortezomib and Vorinostat in Treating Patients With High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia

Biomarkers in Blood Samples From Patients With Acute Myeloid Leukemia

Biomarkers in Blood Samples From Patients With Acute Myeloid Leukemia This study is not yet open for participant recruitment. Verified June 2011 by National Cancer Institute (NCI)…

Continue reading about Clinical Trial Biomarkers in Blood Samples From Patients With Acute Myeloid Leukemia

Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia

Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia This study has been suspended. First Received on October 25, 2006. …

Continue reading about Clinical Trial Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia

Multidrug Resistance Genes in Patients With Acute Myeloid Leukemia

Multidrug Resistance Genes in Patients With Acute Myeloid Leukemia This study is currently recruiting participants. Verified September 2011 by National Cancer Institute (NCI) …

Continue reading about Clinical Trial Multidrug Resistance Genes in Patients With Acute Myeloid Leukemia